๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Risk-Benefit Assessment of Pharmacological Treatments for Panic Disorder

โœ Scribed by Dr Jerry A. Bennett, Molly Moioffer, Sean P. Stanton, Megan Dwight, Paul E. Keck Jr


Book ID
119925010
Publisher
Springer International Publishing AG
Year
1998
Tongue
English
Weight
139 KB
Volume
18
Category
Article
ISSN
0114-5916

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Setting New Standards for the Pharmacolo
โœ R. KUMAR ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 161 KB ๐Ÿ‘ 2 views

Three drugs are currently licensed for the treatment of panic disorder: the benzodiazepine, alprazolam; the tricyclic antidepressant, clomipramine; and, most recently, the selective serotonin reuptake inhibitor, paroxetine. Alprazolam and clomipramine are eective in the treatment of panic disorder,